• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LA-NSCLC 立体定向体部放疗(SBRT)中食管 IGRT 的考虑因素:钡增强 CBCT 和分次间运动。

Oesophageal IGRT considerations for SBRT of LA-NSCLC: barium-enhanced CBCT and interfraction motion.

机构信息

Alfred Health Radiation Oncology, The Alfred, 55 Commercial Road, Melbourne, VIC, 3004, Australia.

Department of Surgery, Central Clinical School, Monash University, Melbourne, VIC, Australia.

出版信息

Radiat Oncol. 2021 Nov 14;16(1):218. doi: 10.1186/s13014-021-01946-8.

DOI:10.1186/s13014-021-01946-8
PMID:34775990
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8591953/
Abstract

BACKGROUND

To determine the optimal volume of barium for oesophageal localisation on cone-beam CT (CBCT) for locally-advanced non-small cell lung cancers (NSCLC) and quantify the interfraction oesophageal movement relative to tumour.

METHODS

Twenty NSCLC patients with mediastinal and/or hilar disease receiving radical radiotherapy were recruited. The first five patients received 25 ml of barium prior to their planning CT and alternate CBCTs during treatment. Subsequent five patient cohorts, received 15 ml, 10 ml and 5 ml. Six observers contoured the oesophagus on each of the 107 datasets and consensus contours were created. Overall 642 observer contours were generated and interobserver contouring reproducibility was assessed. The kappa statistic, dice coefficient and Hausdorff Distance (HD) were used to compare barium-enhanced CBCTs and non-enhanced CBCTs. Oesophageal displacement was assessed using the HD between consensus contours of barium-enhanced CBCTs and planning CTs.

RESULTS

Interobserver contouring reproducibility was significantly improved in barium-enhanced CBCTs compared to non-contrast CBCTs with minimal difference between barium dose levels. Only 10 mL produced a significantly higher kappa (0.814, p = 0.008) and dice (0.895, p = 0.001). The poorer the reproducibility without barium, the greater the improvement barium provided. The median interfraction HD between consensus contours was 4 mm, with 95% of the oesophageal displacement within 15 mm.

CONCLUSIONS

10 mL of barium significantly improves oesophageal localisation on CBCT with minimal image artifact. The oesophagus moves substantially and unpredictably over a course of treatment, requiring close daily monitoring in the context of hypofractionation.

摘要

背景

为了确定在锥形束 CT(CBCT)上对局部晚期非小细胞肺癌(NSCLC)进行食管定位的最佳钡剂体积,并定量测量肿瘤相对的食管分次运动。

方法

共招募了 20 名纵隔和/或肺门疾病接受根治性放疗的 NSCLC 患者。前 5 名患者在其计划 CT 前和治疗过程中的交替 CBCT 中接受了 25ml 钡剂。随后的 5 名患者分别接受了 15ml、10ml 和 5ml 钡剂。6 位观察者在 107 组数据集中的每一组中勾画食管,并创建了共识轮廓。共生成了 642 个观察者轮廓,并评估了观察者间轮廓的可重复性。使用 Kappa 统计、骰子系数和 Hausdorff 距离(HD)比较钡增强 CBCT 和非增强 CBCT。使用 HD 评估钡增强 CBCT 与计划 CT 之间的食管位移。

结果

与非对比 CBCT 相比,钡增强 CBCT 的观察者间轮廓可重复性显著提高,而钡剂量水平之间的差异最小。只有 10ml 产生了更高的 Kappa(0.814,p=0.008)和骰子系数(0.895,p=0.001)。没有钡剂时的可重复性越差,钡剂提供的改善就越大。共识轮廓之间的中位数分次 HD 为 4mm,95%的食管位移在 15mm 以内。

结论

10ml 钡剂可显著提高 CBCT 上的食管定位,且图像伪影最小。食管在治疗过程中会发生大量且不可预测的移动,在分次治疗的情况下需要密切的每日监测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22da/8591953/c731502ffe92/13014_2021_1946_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22da/8591953/4b9b26c8ea1f/13014_2021_1946_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22da/8591953/16d37208ac95/13014_2021_1946_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22da/8591953/f8757d2db058/13014_2021_1946_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22da/8591953/8d54bbfd306b/13014_2021_1946_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22da/8591953/c731502ffe92/13014_2021_1946_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22da/8591953/4b9b26c8ea1f/13014_2021_1946_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22da/8591953/16d37208ac95/13014_2021_1946_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22da/8591953/f8757d2db058/13014_2021_1946_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22da/8591953/8d54bbfd306b/13014_2021_1946_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22da/8591953/c731502ffe92/13014_2021_1946_Fig5_HTML.jpg

相似文献

1
Oesophageal IGRT considerations for SBRT of LA-NSCLC: barium-enhanced CBCT and interfraction motion.LA-NSCLC 立体定向体部放疗(SBRT)中食管 IGRT 的考虑因素:钡增强 CBCT 和分次间运动。
Radiat Oncol. 2021 Nov 14;16(1):218. doi: 10.1186/s13014-021-01946-8.
2
Impact of use of optical surface imaging on initial patient setup for stereotactic body radiotherapy treatments.光学表面成像对立体定向体部放射治疗初始患者摆位的影响。
J Appl Clin Med Phys. 2019 Dec;20(12):149-158. doi: 10.1002/acm2.12779.
3
Accuracy of software-assisted contour propagation from planning CT to cone beam CT in head and neck radiotherapy.头颈部放疗中从计划CT到锥形束CT的软件辅助轮廓传播的准确性。
Acta Oncol. 2016 Nov;55(11):1324-1330. doi: 10.1080/0284186X.2016.1185149. Epub 2016 Aug 24.
4
Incidence and evolution of imaging changes on cone-beam CT during and after radical radiotherapy for non-small cell lung cancer.非小细胞肺癌根治性放疗过程中和放疗后锥形束 CT 成像改变的发生率和演变。
Radiother Oncol. 2019 Mar;132:121-126. doi: 10.1016/j.radonc.2018.12.009. Epub 2018 Dec 31.
5
Accumulation of the delivered dose based on cone-beam CT and deformable image registration for non-small cell lung cancer treated with hypofractionated radiotherapy.基于锥形束 CT 和形变图像配准的递增量在非小细胞肺癌的低分割放射治疗中的应用。
BMC Cancer. 2020 Nov 16;20(1):1112. doi: 10.1186/s12885-020-07617-3.
6
Contrast enhanced oesophageal avoidance for stereotactic body radiotherapy: Barium vs. Gastrografin.立体定向体部放疗中对比剂增强食管避让:钡剂与泛影葡胺的比较
Tech Innov Patient Support Radiat Oncol. 2019 Dec 16;12:16-22. doi: 10.1016/j.tipsro.2019.10.004. eCollection 2019 Dec.
7
Impact of daily soft-tissue image guidance to prostate on pelvic lymph node (PLN) irradiation for prostate patients receiving SBRT.每日软组织影像引导对前列腺接受 SBRT 的患者盆腔淋巴结(PLN)照射的影响。
J Appl Clin Med Phys. 2019 Jul;20(7):121-127. doi: 10.1002/acm2.12665. Epub 2019 Jun 17.
8
Intrafraction 4D-cone beam CT acquired during volumetric arc radiotherapy delivery: kV parameter optimization and 4D motion accuracy for lung stereotactic body radiotherapy (SBRT) patients.容积弧形调强放疗过程中采集的分次内 4D 锥形束 CT:用于肺立体定向体部放疗(SBRT)患者的千伏参数优化和 4D 运动精度。
J Appl Clin Med Phys. 2019 Dec;20(12):10-24. doi: 10.1002/acm2.12755. Epub 2019 Nov 1.
9
Variations of target volume definition and daily target volume localization in stereotactic body radiotherapy for early-stage non-small cell lung cancer patients under abdominal compression.腹部加压下早期非小细胞肺癌患者立体定向体部放射治疗中靶区体积定义及每日靶区体积定位的变化
Med Dosim. 2017;42(2):116-121. doi: 10.1016/j.meddos.2017.01.008. Epub 2017 Apr 19.
10
Dosimetric and volumetric changes in the rectum and bladder in patients receiving CBCT-guided prostate IMRT: analysis based on daily CBCT dose calculation.接受CBCT引导的前列腺调强放疗患者直肠和膀胱的剂量学及容积变化:基于每日CBCT剂量计算的分析
J Appl Clin Med Phys. 2016 Nov 8;17(6):107-117. doi: 10.1120/jacmp.v17i6.6207.

本文引用的文献

1
Assessment of a Contralateral Esophagus-Sparing Technique in Locally Advanced Lung Cancer Treated With High-Dose Chemoradiation: A Phase 1 Nonrandomized Clinical Trial.高剂量放化疗治疗局部晚期肺癌中采用对侧食管保护技术的评估:一项 1 期非随机临床试验。
JAMA Oncol. 2021 Jun 1;7(6):910-914. doi: 10.1001/jamaoncol.2021.0281.
2
Quantifying the Interfractional motion of Esophagus Using Daily Cone Beam Computed Tomography with Oral Contrast During Radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer.使用口服对比剂的每日锥形束 CT 评估局部晚期非小细胞肺癌放疗中食管的分次运动
Pract Radiat Oncol. 2020 Sep-Oct;10(5):e339-e347. doi: 10.1016/j.prro.2020.06.006. Epub 2020 Jun 28.
3
Survival and Toxicity of Hypofractionated Intensity Modulated Radiation Therapy in 4 Gy Fractions for Unresectable Stage III Non-Small Cell Lung Cancer.
4 Gy 亚分次调强放疗治疗不可切除的 III 期非小细胞肺癌的生存和毒性。
Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):710-719. doi: 10.1016/j.ijrobp.2020.03.038. Epub 2020 Apr 7.
4
Contrast enhanced oesophageal avoidance for stereotactic body radiotherapy: Barium vs. Gastrografin.立体定向体部放疗中对比剂增强食管避让:钡剂与泛影葡胺的比较
Tech Innov Patient Support Radiat Oncol. 2019 Dec 16;12:16-22. doi: 10.1016/j.tipsro.2019.10.004. eCollection 2019 Dec.
5
Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer.NRG肿瘤学RTOG 0617的长期结果:不可切除的III期非小细胞肺癌采用标准剂量与高剂量放化疗联合或不联合西妥昔单抗的疗效对比
J Clin Oncol. 2020 Mar 1;38(7):706-714. doi: 10.1200/JCO.19.01162. Epub 2019 Dec 16.
6
Image-guidance triggered adaptive replanning of radiation therapy for locally advanced lung cancer: an evaluation of cases requiring plan adaptation.图像引导触发的局部晚期肺癌放射治疗自适应计划调整:需要调整计划的病例评估。
Br J Radiol. 2020 Jan;93(1105):20190743. doi: 10.1259/bjr.20190743. Epub 2019 Nov 13.
7
Stage III Non-small Cell Lung Cancer Management in England.英格兰 III 期非小细胞肺癌的管理。
Clin Oncol (R Coll Radiol). 2019 Oct;31(10):688-696. doi: 10.1016/j.clon.2019.07.020.
8
Predicting High-Grade Esophagus Toxicity After Treating Central Lung Tumors With Stereotactic Radiation Therapy Using a Normal Tissue Complication Probability Model.使用正常组织并发症概率模型预测立体定向放疗治疗中央肺肿瘤后的高级别食管毒性。
Int J Radiat Oncol Biol Phys. 2020 Jan 1;106(1):73-81. doi: 10.1016/j.ijrobp.2019.08.059. Epub 2019 Sep 6.
9
Recognizing Radiation Therapy-related Complications in the Chest.识别胸部放疗相关并发症。
Radiographics. 2019 Mar-Apr;39(2):344-366. doi: 10.1148/rg.2019180061.
10
The acute and late toxicity results of a randomized phase II dose-escalation trial in non-small cell lung cancer (PET-boost trial).随机 II 期剂量递增试验在非小细胞肺癌中的急性和晚期毒性结果(PET-boost 试验)。
Radiother Oncol. 2019 Feb;131:166-173. doi: 10.1016/j.radonc.2018.09.019. Epub 2018 Oct 13.